Molecular characteristics and virulence factors in methicillin-susceptible, resistant, and heterogeneous vancomycin-intermediate Staphylococcus aureus from central-southern China

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 5, 2015, Pages 490-496

  Liu, Cailin ^a   Chen, Zhong ju ^a   Sun, Ziyong ^a   Feng, Xianju ^b   Zou, Mingxiang ^c   Cao, Wei ^d   Wang, Shanmei ^e   Zeng, Ji ^a   Wang, Yue ^a   Sun, Mingyue ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Heterogeneous vancomycin intermediate Staphylococcus aureus; Methicillin resistant Staphylococcus aureus; Molecular; Staphylococcus aureus; Virulence gene

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; EXFOLIATIN; GENTAMICIN; HEMOLYSIN; LEVOFLOXACIN; LINEZOLID; RIFAMPICIN; STAPHYLOCOCCUS ENTEROTOXIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CONTROLLED STUDY; GENE FREQUENCY; LUKED GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PVL GENE; TST GENE; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; CLASSIFICATION; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

CHINA; GENETIC VARIATION; GENOTYPE; HUMANS; METHICILLIN RESISTANCE; PHENOTYPE; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE; VIRULENCE FACTORS;

EID: 84943580452     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.03.003     Document Type: Article

References (31)

1. Ogston A. Micrococcus poisoning. J Anat Physiol 1882, 17(Pt 1):24-58.
2. Smith G. Ogston's coccus: 102 years and still going strong. South Med J 1982, 75:1559-1562.
3. Kawaguchiya M., Urushibara N., Yamamoto D., Yamashita T., Shinagawa M., Watanabe N., et al. Characterization of PVL/ACME-positive methicillin-resistant Staphylococcus aureus (genotypes ST8-MRSA-IV and ST5-MRSA-II) isolated from a university hospital in Japan. Microb Drug Resist 2013, 19:48-56.
4. Zhao C., Liu Y., Zhao M., Liu Y., Yu Y., Chen H., et al. Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398. PLoS One 2012, 7:e38577.
5. Jiménez J.N., Ocampo A.M., Vanegas J.M., Rodríguez E.A., Garcés C.G., Patiño L.A., et al. Characterisation of virulence genes in methicillin susceptible and resistant Staphylococcus aureus isolates from a paediatric population in a university hospital of Medellin, Colombia. Mem Inst Oswaldo Cruz 2011, 106:980-985.
6. Wu D., Li X., Yang Y., Zheng Y., Wang C., Deng L., et al. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired methicillin-resistant Staphylococcus aureus isolated from Chinese children. J Med Microbiol 2011, 60(Pt 1):35-45.
7. Park K.H., Kim E.S., Kim H.S., Park S.J., Bang K.M., Park H.J., et al. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. J Antimicrob Chemother 2012, 67:1843-1849.
8. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997, 350:1670-1673.
9. Liu C., Chambers H.F. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003, 47:3040-3045.
10. Howden B.P., Davies J.K., Johnson P.D., Stinear T.P., Grayson M.L. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010, 23:99-139.
11. Rong S.L., Leonard S.N. Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance. Ann Pharmacother 2010, 44:844-850.
12. Sun W., Chen H., Liu Y., Zhao C., Nichols W.W., Chen M., et al. Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrob Agents Chemother 2009, 53:3642-3649.
13. Wootton M., Howe R.A., Hillman R., Walsh T.R., Bennett P.M., MacGowan A.P. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001, 47:399-403.
14. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
15. Argudin M.A., Tenhagen B.A., Fetsch A., Sachsenroder J., Kasbohrer A., Schroeter A., et al. Virulence and resistance determinants of German Staphylococcus aureus ST398 isolates from nonhuman sources. Appl Environ Microbiol 2011, 77:3052-3060.
16. Milheirico C., Oliveira D.C., de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:3374-3377.
17. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
18. Wang W.Y., Lee S.Y., Chiueh T.S., Lu J.J. Molecular and phenotypic characteristics of methicillin-resistant and vancomycin -intermediate Staphylococcus aureus isolates from patients with septic arthritis. J Clin Microbiol 2009, 47:3617-3623.
19. Harmsen D., Claus H., Witte W., Rothganger J., Turnwald D., Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003, 41:5442-5448.
20. Casapao A.M., Leonard S.N., Davis S.L., Lodise T.P., Patel N., Goff D.A., et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bloodstream infection. Antimicrob Agents Chemother 2013.
21. Joo J., Yamaki J., Lou M., Hshieh S., Chu T., Shriner K.A., et al. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy. Clin Ther 2013, 35:995-1004.
22. Pereira C.A., Marra A.R., Camargo L.F., Pignatari A.C., Sukiennik T., Behar P.R., et al. Nosocomial bloodstream infections in brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One 2013, 8:e68144.
23. Yu F., Li T., Huang X., Xie J., Xu Y., Tu J., et al. Virulence gene profiling and molecular characterization of hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection. Diagn Microbiol Infect Dis 2012, 74:363-368.
24. Fong R.K., Low J., Koh T.H., Kurup A. Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore. Eur J Clin Microbiol Infect Dis 2009, 28:983-987.
25. Lin S.Y., Chen T.C., Chen F.J., Chen Y.H., Lin Y.I., Kristopher Siu L., et al. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center. J Microbiol Immunol Infect 2012, 45:435-441.
26. Gill S.R., Fouts D.E., Archer G.L., Mongodin E.F., Deboy R.T., Ravel J., et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 2005, 187:2426-2438.
27. Collins J., Rudkin J., Recker M., Pozzi C., O'Gara J.P., Massey R.C. Offsetting virulence and antibiotic resistance costs by MRSA. ISME J 2010, 4:577-584.
28. Otto M. Basis of virulence in community-associated methicillin-resistant. Staphylococcus aureus. Annu Rev Microbiol 2010, 64:143-162.
29. Kim T., Yi J., Hong K.H., Park J.S., Kim E.C. Distribution of virulence genes in spa types of methicillin-resistant Staphylococcus aureus isolated from patients in intensive care units. Korean J Lab Med 2011, 31:30-36.
30. Liu Y., Wang H., Du N., Shen E., Chen H., Niu J., et al. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother 2009, 53:512-518.
31. Cheng H., Yuan W., Zeng F., Hu Q., Shang W., Tang D., et al. Molecular and phenotypic evidence for the spread of three major methicillin-resistant Staphylococcus aureus clones associated with two characteristic antimicrobial resistance profiles in China. J Antimicrob Chemother 2013, 68:2453-2457.